国内学者眼科领域系统评价和Meta分析在SCI期刊的发表情况

Situation of published systematic reviews and Meta-analysis in SCI journals in the field of ophthalmology by Chinese authors

目的统计分析目前国内学者在SCI期刊发表的眼科领域系统评价和Meta分析论文情况,为今后发表此类研究提供参考。设计描述性研究。研究对象在PubMed、EMBASE及Cochrane library三大数据库中收录的所有眼科领域的系统评价和Meta分析论文。方法系统检索PubMed、EMBASE及Cochrane library三大数据库。检索时,限定研究对象为人类,语言为英语,检索时间截止到2017年1月30日。通过阅读标题、摘要及全文,排除重复及不相关研究,将最终符合条件的研究按作者来源、发表年限、疾病类型等进行归类分析。主要指标作者来源、发表年限、疾病类型。结果三大数据库共检索到10 551条题录(PubMed 4214,EMBASE 6155,Cochrane library 182)。排除重复及不相关研究后,最终符合条件的系统评价和Meta分析442篇。此类研究最早发表于2004年,按年发表量排名,前三名分别是:2015(100篇,22.62%)、2014(91篇,20.59%)、2016(90篇,20.36%)。共有来自52个城市的作者参与发表过此类研究,前三名城市分别是:上海(95篇,21.49%)、北京(45篇,10.18%)、广州(38篇,8.60%)。共有126种杂志发表此类研究,前三名杂志分别是:PLoS One (79篇,17.87%)、Molecular Vision(16篇,3.62%)、BMC Ophthalmology(15篇,3.39%)。研究内容以视网膜疾病最多,前三名疾病分别是:视网膜疾病(168篇,38.01%)、青光眼(95篇,21.49%)、屈光手术(47篇,10.63%)。定性系统评价17篇(3.85%),Meta分析425篇(96.15%)。在Meta分析中干预性研究177篇,观察性研究248篇,后者以基因相关研究(137篇)、危险因素(84篇)为主。结论国内学者在眼科领域系统评价发表量逐年增多,作者主要集中于国内大城市,尤其是上海和北京,研究热点主要是视网膜疾病、青光眼,非干预性研究发表量已超越干预性研究,其中以基因相关研究及危险因素研究为主。

Objective To investigate the present situation of systematic reviews and Meta-analysis published in SCI journals in the field of ophthalmology by Chinese scholars,and to provide experiences for authors who want to report this kind of studies in the future. Design Descriptive research. Participants All the systematic reviews and Meta-analysis in the field of ophthalmology published in PubMed, EMBASE database and Cochrane library. Methods PubMed, EMBASE database and Cochrane library were systematically searched for relevant studies up to 30 January 2017. After excluding duplicated and unrelated studies by reading titles, abstracts and full texts, the final included studies were categorized according to author affiliations, publication years, types of disease and so on. Main Outcome Measures Author affiliations, publication years, types of disease. Results A total of 10 551 studies were identified from the three database (PubMed 4214, EMBASE 6155, Cochrane library 182). After excluding duplicated and unrelated studies, 442 studies were included in the final analysis. This kind of study was first published in 2004. The top three were: 2015 (100, 22.62%), 2014 (91, 20.59%) and 2016 (90, 20.36%) ranked by the number of publication. Authors coming from 52 cities participated in the publication of these articles. The top three cities were Shanghai (95, 21.49%), Beijing (45, 10.18%) and Guangzhou (38, 8.60%). A total of 126 different journals published these studies, and the top three journals were PLoS One (79, 17.87%), Molecular Vision (16, 3.62%), and BMC Ophthalmology (15, 3.39%). Retinal diseases were the most in these studies. The top three diseases were retinal diseases (168, 38.01%), glaucoma (95, 21.49%) and refractive surgery (47, 10.63%). Qualitative systematic reviews were 17 (3.85%) and Metaanalysis were 425 (96.15%). In Meta-analysis, intervention study was in 177 studies, and non-intervention studies was in 248 studies which were based on gene related studies (137) and risk factors (84). Conclusion The amount of systematic reviews and Meta-analysis in the field of ophthalmology by Chinese author has been increased year by year.The author mainly come from big cities in China,especially Shanghai and Beijing.The main research focuses on the retinal diseases and glaucoma.Non-intervention research published more than intervention studies,and the latter was based on gene related research and risk factors research.